Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis

Gastroenterol Hepatol. 2022 Dec;45(10):753-766. doi: 10.1016/j.gastrohep.2022.01.007. Epub 2022 Jan 31.
[Article in English, Spanish]

Abstract

Introduction: This study aimed to collect and summarize test data and conduct a meta-analysis, with respect to the Multitarget Stool DNA test sensitivity and specificity, compared to colonoscopy.

Material and methods: All manuscripts were screened for eligibility according to inclusion criteria. Participants were a normal population at an average risk of developing CRC. Intervention was Stool based and DNA panel tests compared with colonoscopy, and outcome was detection of CRC and any pre-cancerous lesions. Inter-study and inconsistency (using the I-squared test) were assessed.

Results: Meta-analyses of the Mt-sDNA test showed a combined sensitivity of 89%, 51%, and 76% for the detection of CRC, advanced adenoma (AA), and combined CRC and AA, respectively. The overall specificity was 91%, 89%, and 90% for the detection of CRC, AA, and combined CRC and AA, respectively.

Conclusion: Mt-sDNA had significantly acceptable diagnostic accuracy for CRC and AA diagnosis, but still has lower sensitivity and specificity than colonoscopy.

Keywords: Accuracy; Colorectal cancer; Cáncer colorrectal; Exactitud; Multiobjetivo; Multitarget; Poner en pantalla; Prueba de heces; Screening; Stool test.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Adenoma* / diagnosis
  • Adenoma* / genetics
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / genetics
  • DNA / analysis
  • Early Detection of Cancer / methods
  • Humans
  • Mass Screening / methods
  • Occult Blood

Substances

  • DNA